Last reviewed: June 18, 2026

Last updated: June 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide has emerged as a breakthrough weight management medication, with clinical trials showing an average weight loss of 15% over 68 weeks in people with obesity. This injectable GLP-1 medication works by mimicking a natural hormone that signals fullness and reduces cravings. PlexusDx delivers pharmaceutical-grade semaglutide from licensed 503A compounding pharmacies directly to all 50 states, starting at $149 per month.

How Semaglutide Works in Your Body

Semaglutide activates GLP-1 receptors in your brain, pancreas, and digestive tract. This activation slows gastric emptying—the speed at which food moves through your stomach—which extends feelings of fullness between meals. The medication also increases insulin secretion when blood sugar rises and decreases glucagon when it falls, helping regulate your glucose metabolism naturally.

The appetite-suppressing effect typically becomes noticeable within the first 1–2 weeks of injections. Most patients report eating smaller portions without conscious restriction, reduced cravings for high-calorie foods, and improved satiety from normal meal sizes. These changes happen at the neurochemical level, not through willpower alone, making weight loss feel more sustainable for many users.

Starting Your Semaglutide Injection Schedule

Semaglutide is administered once weekly as a subcutaneous injection, typically in the abdomen, thigh, or upper arm. Treatment begins with a low starting dose to allow your body to adjust and minimize side effects. Your dose may need to go up. Your price won't. PlexusDx maintains flat monthly pricing regardless of dose level, so cost remains predictable as your provider adjusts your therapy.

Most patients follow a 4-week titration schedule, increasing their injection strength every 7 days until reaching a therapeutic maintenance dose. You'll self-inject using a pre-filled pen that takes less than 10 seconds per injection. Your healthcare provider determines your exact schedule based on your response, medical history, and weight loss goals. Consistency matters—taking your injection on the same day each week helps you build the habit and maintain steady medication levels.

Expected Weight Loss Results and Timeline

Clinical data shows that 87% of people taking semaglutide lost at least 5% of their starting body weight over one year. The average weight loss ranges from 10–15% of body weight, though some patients achieve 20% or greater reductions. Weight loss typically accelerates after the first month as your dose increases and your body adapts to the medication's appetite-suppressing effects.

Most patients notice measurable changes by week 4–6 of treatment, with more dramatic results appearing between weeks 8 and 16. After 6 months, the majority of responders reach a weight loss plateau, where their body stabilizes at a lower weight. Continuing the medication maintains this lower weight; stopping semaglutide often leads to gradual weight regain over several months unless lifestyle habits remain significantly changed.

Managing Side Effects and What to Expect

Common side effects during the first weeks include mild nausea, vomiting, constipation, or diarrhea. These effects typically decrease in intensity as your body adjusts and usually resolve within 2–4 weeks. Eating smaller, more frequent meals and staying hydrated can reduce nausea. If constipation occurs, increasing dietary fiber and water intake, along with gentle exercise, helps restore normal digestion.

Serious side effects are rare but require medical attention: severe abdominal pain, persistent vomiting, vision changes, or signs of pancreatitis demand immediate contact with your healthcare provider. Semaglutide is not recommended for people with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2. Your PlexusDx provider reviews your full medical history before starting treatment to ensure semaglutide is safe for you.

Personalizing Your Treatment With Genetic Insights

Individual responses to semaglutide vary significantly based on genetic factors affecting appetite regulation, glucose metabolism, and fat distribution. PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides using variants like GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313. These insights reveal how your body processes hunger signals and energy storage, informing whether semaglutide alone or a combination therapy like GLP-Squared (semaglutide plus tirzepatide) may work better for your genetics.

Understanding your peptide pathways helps PlexusDx providers optimize your starting dose, predict side effect tolerance, and determine when to consider alternative compounds. The genetic test costs $99 as an add-on after your first month of treatment, giving your provider real data rather than guesswork. Patients with certain genetic profiles respond exceptionally well to semaglutide, while others benefit from dual-mechanism therapy tailored to their unique metabolism.

Cost and Access: How PlexusDx Delivers Affordability

PlexusDx compounded semaglutide injections start at $149 per month through licensed 503A compounding pharmacies. No insurance is required, no membership fees apply, and the medication is HSA/FSA eligible. This pricing structure makes semaglutide accessible to people regardless of insurance status or employment, removing a major barrier to weight loss therapy.

All medications ship directly to your home in all 50 states. Your dose may need to go up. Your price won't—PlexusDx maintains flat pricing across all dose levels, so you never face surprise cost increases as your therapy evolves. If you're considering adding genetic testing or exploring oral semaglutide ($249/mo) or dual-mechanism GLP-Squared therapy, your PlexusDx team discusses options transparently before any changes.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How quickly will I see weight loss results from semaglutide injections?

Most patients notice appetite reduction and early weight changes by week 2–4, with measurable scale changes appearing by week 6. Significant weight loss typically accelerates between weeks 8 and 16. Full response develops over 3–6 months, with clinical trials showing average losses of 10–15% of body weight over one year of consistent treatment.

Can I take semaglutide if I have diabetes or other health conditions?

Semaglutide is approved for type 2 diabetes and weight management, making it particularly valuable for people with both conditions. However, certain conditions—including personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, severe kidney disease, or active gallbladder disease—require careful evaluation. PlexusDx providers review your complete medical history during the intake process to confirm semaglutide's safety for you.

Why does PlexusDx pricing stay flat even when my dose increases?

PlexusDx charges one flat monthly rate ($149–$189 depending on your commitment tier) regardless of your injection strength. Your dose may need to go up. Your price won't. This approach removes cost anxiety and ensures predictable budgeting as your provider titrates your medication to find your optimal therapeutic dose.

What happens to my weight if I stop taking semaglutide?

Weight regain typically begins 2–3 months after stopping semaglutide, as your appetite hormones gradually return to baseline. However, many people maintain 30–50% of their weight loss if they've established sustainable eating and exercise habits during treatment. Long-term weight maintenance usually requires either continuing semaglutide or maintaining significant lifestyle changes learned during therapy.

How does PlexusDx's genetic testing help personalize my semaglutide therapy?

PlexusDx Precision Peptide Genetic Test identifies your genetic variants in appetite-control genes (GLP1R, GIPR, MC4R) and metabolism genes (FTO), mapping 14 pathways across 49 peptides. These insights show whether your body is a strong semaglutide responder or might benefit from combination therapy like GLP-Squared, plus predict your likely side effect tolerance. At $99, the test is available one month after starting treatment and directly informs dose optimization.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves